Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma (vol 24, pg 1649, 2018)

被引：11

作者：

Amaria, Rodabe N.

Reddy, Sangeetha M.

Tawbi, Hussein A.

Davies, Michael A.

Ross, Merrick I.

Glitza, Isabella C.

Cormier, Janice N.

Lewis, Carol

Hwu, Wen-Jen

Hanna, Ehab

Diab, Adi

Wong, Michael K.

Royal, Richard

Gross, Neil

Weber, Randal

Lai, Stephen Y.

Ehlers, Richard

Blando, Jorge

Milton, Denai R.

Woodman, Scott

Kageyama, Robin

Wells, Daniel K.

Hwu, Patrick

Patel, Sapna P.

Lucci, Anthony

Hessel, Amy

Lee, Jeffrey E.

Gershenwald, Jeffrey

Simpson, Lauren

Burton, Elizabeth M.

Posada, Liberty

Haydu, Lauren

Wang, Linghua

Zhang, Shaojun

Lazar, Alexander J.

Hudgens, Courtney W.

Gopalakrishnan, Vancheswaran

Reuben, Alexandre

Andrews, Miles C.

Spencer, Christine N.

Prieto, Victor

Sharma, Padmanee

Allison, James

Tetzlaff, Michael T.

Wargo, Jennifer A.

机构：

[1] MD Anderson Cancer Center,Department of Melanoma Medical Oncology

[2] MD Anderson Cancer Center,Department of Breast Medical Oncology

[3] MD Anderson Cancer Center,Department of Surgical Oncology

[4] MD Anderson Cancer Center,Department of Head and Neck Surgery

[5] MD Anderson Cancer Center,Department of Immunology

[6] MD Anderson Cancer Center,Department of Biostatistics

[7] Parker Institute for Cancer Immunotherapy,Department of Genomic Medicine

[8] MD Anderson Cancer Center,Department of Pathology

[9] MD Anderson Cancer Center,Department of Genitourinary Cancers

[10] MD Anderson Cancer Center,Department of Translational and Molecular Pathology

[11] MD Anderson Cancer Center,undefined

来源：

NATURE MEDICINE | 2018年 / 24卷 / 12期

关键词：

D O I：

10.1038/s41591-018-0252-y

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

In the version of this article originally published, there was an error in Fig. 1. In the neoadjuvant phase column, the n values for arms A and B were both reported to be 20. The n values for arms A and B were actually 12 and 11, respectively. Also, the URL underlying the accession code in the data availability section was incorrect. The URL was originally https://www.ebi.ac.uk/ega/studies/EGAS00001002698. It should have been https://www.ebi.ac.uk/ega/studies/EGAS00001003178. The errors have been corrected in the print, HTML and PDF versions of this article.

引用

页码：1942 / 1942

页数：1

共 50 条

[41] Contemporary Neoadjuvant Therapies for High-Risk Melanoma: A Systematic Review
Boulva, Kerianne
Apte, Sameer
Yu, Ashley
Tran, Alexandre
Shorr, Risa
Song, Xinni
Ong, Michael
Nessim, Carolyn
CANCERS, 2021, 13 (08)
[42] Efficacy of neoadjuvant chemotherapy in patients with high-risk resectable colorectal liver metastases
Ninomiya, Mizuki
Emi, Yasunori
Motomura, Takashi
Tomino, Takahiro
Iguchi, Tomohiro
Kayashima, Hiroto
Harada, Noboru
Uchiyama, Hideaki
Nishizaki, Takashi
Higashi, Hidefumi
Kuwano, Hiroyuki
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (12) : 2255 - 2264
[43] Efficacy of neoadjuvant chemotherapy in patients with high-risk resectable colorectal liver metastases
Mizuki Ninomiya
Yasunori Emi
Takashi Motomura
Takahiro Tomino
Tomohiro Iguchi
Hiroto Kayashima
Noboru Harada
Hideaki Uchiyama
Takashi Nishizaki
Hidefumi Higashi
Hiroyuki Kuwano
International Journal of Clinical Oncology, 2021, 26 : 2255 - 2264
[44] Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis (vol 24, pg 1804, 2018)
Wang, Yinghong
Wiesnoski, Diana H.
Helmink, Beth A.
Gopalakrishnan, Vancheswaran
Choi, Kati
DuPont, Hebert L.
Jiang, Zhi-Dong
Abu-Sbeih, Hamzah
Sanchez, Christopher A.
Chang, Chia-Chi
Parra, Edwin R.
Francisco-Cruz, Alejandro
Raju, Gottumukkala S.
Stroehlein, John R.
Campbell, Matthew T.
Gao, Jianjun
Subudhi, Sumit K.
Maru, Dipen M.
Blando, Jorge M.
Lazar, Alexander J.
Allison, James P.
Sharma, Padmanee
Tetzlaff, Michael T.
Wargo, Jennifer A.
Jenq, Robert R.
NATURE MEDICINE, 2019, 25 (01) : 188 - 188
[45] Neoadjuvant Immunotherapy for High-Risk, Resectable Malignancies: Scientific Rationale and Clinical Challenges
Krishnamoorthy, Mithunah
Lenehan, John G.
Vareki, Saman Maleki
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (07): : 823 - 832
[46] Risk factors of immune checkpoint inhibitor-related pneumonitis after neoadjuvant immunochemotherapy for resectable NSCLC
Mao, Zhirong
Pang, Guanchao
Huang, Xiaojie
Chen, Xiuxiu
Wu, Jiaji
Xu, Xia
Teng, Zhihua
Tan, Yanbin
Wang, Pingli
BMC PULMONARY MEDICINE, 2024, 24 (01):
[47] Combined immune checkpoint inhibition for high-risk urothelial carcinoma
Tregunna R.
Nature Reviews Urology, 2020, 17 (12) : 658 - 658
[48] Clinicopathological Features, Staging, and Current Approaches to Treatment in High-Risk Resectable Melanoma
Keung, Emily Z.
Gershenwald, Jeffrey E.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (09): : 875 - 885
[49] Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma (vol 38, pg 500, 2020)
Grasso, Catherine S.
Tsoi, Jennifer
Onyshchenko, Mykola
Abril-Rodriguez, Gabriel
Ross-Macdonald, Petra
Wind-Rotolo, Megan
Champhekar, Ameya
Medina, Egmidio
Torrejon, Davis Y.
Shin, Daniel Sanghoon
Phuong Tran
Kim, Yeon Joo
Puig-Saus, Cristina
Campbell, Katie
Vega-Crespo, Agustin
Quist, Michael
Martignier, Christophe
Luke, Jason J.
Wolchok, Jedd D.
Johnson, Douglas B.
Chmielowski, Bartosz
Hodi, F. Stephen
Bhatia, Shailender
Sharfman, William
Urba, Walter J.
Slingluff, Craig L., Jr.
Diab, Adi
Haanen, John B. A. G.
Algarra, Salvador Martin
Pardoll, Drew M.
Anagnostou, Valsamo
Topalian, Suzanne L.
Velculescu, Victor E.
Speiser, Daniel E.
Kalbasi, Anusha
Ribas, Antoni
CANCER CELL, 2021, 39 (01) : 122 - 122
[50] Adjuvant and Neoadjuvant Therapy in High-Risk Stage III Cutaneous Melanoma
Sondak, Vernon K.
Khushalani, Nikhil I.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 16 - 17

← 1 2 3 4 5 →